Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone posterior segment drug delivery system for anterior uveitis
2006-000737-36Phase 3Terminated
- Sponsor
- Allergan
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in cyclitis (3 arms), sponsored by Allergan. Primary endpoint: Primary efficacy endpoint. Started Feb 2006; status: terminated.
02
Drugs
dexamethasone
03
Conditions
cyclitis
Beyond the preview
Go deeper on 2006-000737-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000737-36.